Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
Tarsila Mendes de Camargo, Elisângela Oliveira de Freitas, Alba Marina Gimenez, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Optimizing oncolytic virotherapy in cancer treatment
Kevin J. Harrington, Daniel J. Freeman, Elizabeth J. Kelly, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 9, pp. 689-706
Closed Access | Times Cited: 426
Plasmodium genomics: an approach for learning about and ending human malaria
José Antonio Garrido-Cárdenas, Lilia González-Cerón, Francisco Manzano‐Agugliaro, et al.
Parasitology Research (2018) Vol. 118, Iss. 1, pp. 1-27
Open Access | Times Cited: 70
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages
Yevel Flores-García, Sonia M. Herrera, Hugo Jhun, et al.
Malaria Journal (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 67
The immunology of Plasmodium vivax malaria
Lis Ribeiro do Valle Antonelli, Caroline Junqueira, Joseph M. Vinetz, et al.
Immunological Reviews (2019) Vol. 293, Iss. 1, pp. 163-189
Closed Access | Times Cited: 60
Plasmodium vivax vaccine: What is the best way to go?
Gisele Tatiane Soares da Veiga, Matheus Ribeiro Moriggi, Jean Franciesco Vettorazzi, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 19
Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells
Cristina Poveda, Ana Carolina Leão, Chiara Mancino, et al.
Current Research in Immunology (2023) Vol. 4, pp. 100066-100066
Open Access | Times Cited: 15
Vaccination With Sporozoites: Models and Correlates of Protection
Yun Shan Goh, Daniel McGuire, Laurent Rénia
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 41
Progress towards the development of a P. vivax vaccine
Sai Lata De, Francis B. Ntumngia, Justin Nicholas, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 2, pp. 97-112
Open Access | Times Cited: 29
EVALUATING THE STORAGE STABILITY OF A Plasmodium vivax CIRCUMSPOROZOITE PROTEIN VACCINE CANDIDATE
Janaína Tenorio Novais, Rodolfo Ferreira Marques, Alba Marina Gimenez, et al.
Process Biochemistry (2025)
Closed Access
Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine Candidate
Yang Xu, Ziyou Zhou, Brad Brooks, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
Rodolfo Ferreira Marques, Filipe Menegatti de Melo, Janaína Tenorio Novais, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles
Alba Marina Gimenez, Ahmed M. Salman, Rodolfo Ferreira Marques, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein
Rodolfo Ferreira Marques, Alba Marina Gimenez, Eduardo Aliprandini, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 190-190
Open Access | Times Cited: 12
Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant
Rodolfo Ferreira Marques, Alba Marina Gimenez, Otávia L. Caballero, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2394-2406
Closed Access | Times Cited: 1
Poly I:C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice
Tiffany B. L. Costa-Gouvea, Kátia Sanches Françoso, Rodolfo Ferreira Marques, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Immunological evaluation of two novel engineered Plasmodium vivax circumsporozoite proteins formulated with different human-compatible vaccine adjuvants in C57BL/6 mice
Samaneh H. Shabani, Sedigheh Zakeri, Yousef Mortazavi, et al.
Medical Microbiology and Immunology (2019) Vol. 208, Iss. 6, pp. 731-745
Open Access | Times Cited: 11
Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development
Yukiko Miyazaki, Catherin Marin-Mogollon, Takashi Imai, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 11
Genetic diversity of circumsporozoite protein in Plasmodium knowlesi isolates from Malaysian Borneo and Peninsular Malaysia
Eric Tzyy Jiann Chong, Joveen Wan Fen Neoh, Tiek Ying Lau, et al.
Malaria Journal (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates
Young Chan Kim, Bárbara Dema, Roberto Rodríguez-García, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 363-363
Open Access | Times Cited: 9
A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of Plasmodium vivax Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic Plasmodium berghei Parasite
Luciana Chagas Lima, Rodolfo Ferreira Marques, Alba Marina Gimenez, et al.
Microorganisms (2020) Vol. 8, Iss. 6, pp. 916-916
Open Access | Times Cited: 8
Protective Immunity in Mice Immunized With P. vivax MSP119-Based Formulations and Challenged With P. berghei Expressing PvMSP119
Irina Dobrescu, Tarsila Mendes de Camargo, Alba Marina Gimenez, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 8
Genetic approach towards a vaccine against malaria
José Antonio Garrido-Cárdenas, Concepción Mesa-Valle, Francisco Manzano‐Agugliaro
European Journal of Clinical Microbiology & Infectious Diseases (2018) Vol. 37, Iss. 10, pp. 1829-1839
Closed Access | Times Cited: 6
Assessing Malaria Vaccine Efficacy
Laurent Rénia, Yun Shan Goh, Kaitian Peng, et al.
InTech eBooks (2018)
Open Access | Times Cited: 2
Putative circumsporozoite protein (CSP) of Plasmodium vivax is considerably distinct from the well-known CSP and plays a role in the protein ubiquitination pathway
Manoswini Dash, Veena Pande, Abhinav Sinha
Gene (2019) Vol. 721, pp. 100024-100024
Open Access | Times Cited: 2
Genetic diversity of circumsporozoite protein in Plasmodium knowlesi isolates from Malaysian Borneo and Peninsular Malaysia
Eric Tzyy Jiann Chong, Joveen Wan Fen Neoh, Tiek Ying Lau, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top